Exact Mass: 333.12460180000005

Exact Mass Matches: 333.12460180000005

Found 127 metabolites which its exact mass value is equals to given mass value 333.12460180000005, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Pirimiphosethyl

Pirimiphos-ethyl

C13H24N3O3PS (333.1275924)


CONFIDENCE standard compound; INTERNAL_ID 623; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10152; ORIGINAL_PRECURSOR_SCAN_NO 10151 CONFIDENCE standard compound; INTERNAL_ID 623; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10138; ORIGINAL_PRECURSOR_SCAN_NO 10137 CONFIDENCE standard compound; INTERNAL_ID 623; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10202; ORIGINAL_PRECURSOR_SCAN_NO 10201 CONFIDENCE standard compound; INTERNAL_ID 623; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10195; ORIGINAL_PRECURSOR_SCAN_NO 10194 CONFIDENCE standard compound; INTERNAL_ID 623; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10210; ORIGINAL_PRECURSOR_SCAN_NO 10209 CONFIDENCE standard compound; INTERNAL_ID 623; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 10096; ORIGINAL_PRECURSOR_SCAN_NO 10095

   

[(1S)-2-[2-[(2R)-2-amino-2-carboxyethyl]sulfinyl-1H-imidazol-5-yl]-1-carboxyethyl]-trimethylazanium

[(1S)-2-[2-[(2R)-2-amino-2-carboxyethyl]sulfinyl-1H-imidazol-5-yl]-1-carboxyethyl]-trimethylazanium

C12H21N4O5S+ (333.12325960000004)


   

gamma-Glutamyltryptophan

(2S)-2-amino-4-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C16H19N3O5 (333.1324644)


gamma-Glutamyltryptophan is a dipeptide composed of gamma-glutamate and tryptophan, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. gamma-Glutamyltryptophan is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.

   

Glutamyltryptophan

(4S)-4-amino-4-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C16H19N3O5 (333.1324644)


Glutamyltryptophan is a dipeptide composed of glutamate and tryptophan, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Glutamyltryptophan is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. Glutamyltryptophan can be found in feces (PMID: 27015276). The synthetic version of this dipeptide is named Oglufanide. It was originally developed to treat severe infectious disease in Russia (where it is a registered pharmaceutical), and was extensively studied in cancer clinical trials in the United States before being acquired by Implicit Bioscience in 2005. Oglufanide works as a regulator of the bodys immune response and is being given by intranasal administration to patients with chronic hepatitis C viral infection (DB05779). C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C308 - Immunotherapeutic Agent Oglufanide (H-Glu-Trp-OH) is a dipeptide immunomodulator isolated from calf thymus. Oglufanide inhibits vascular endothelial growth factor (VEGF). Oglufanide can stimulate the immune response to hepatitic C virus (HCV) and intracellular bacterial infections. Oglufanide shows antitumor and anti-angiogenesis activities[1][2][3]. Oglufanide (H-Glu-Trp-OH) is a dipeptide immunomodulator isolated from calf thymus. Oglufanide inhibits vascular endothelial growth factor (VEGF). Oglufanide can stimulate the immune response to hepatitic C virus (HCV) and intracellular bacterial infections. Oglufanide shows antitumor and anti-angiogenesis activities[1][2][3].

   

Tryptophyl-Glutamate

2-{[2-amino-1-hydroxy-3-(1H-indol-3-yl)propylidene]amino}pentanedioate

C16H19N3O5 (333.1324644)


Tryptophyl-Glutamate is a dipeptide composed of tryptophan and glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.

   

10-Acetoxydecarbamoylmitomycin C

{11-amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.0^{2,7}.0^{4,6}]trideca-1(9),11-dien-8-yl}methyl acetate

C16H19N3O5 (333.1324644)


   

Golotimod

2-amino-4-{[1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}butanoic acid

C16H19N3O5 (333.1324644)


   

6-Hydroxy-3-ketoveprisine

6-Hydroxy-3-ketoveprisine

C17H19NO6 (333.1212314)


   
   
   
   
   

9-hydroxy-2-nonenoic lactone mercapturic acid

9-hydroxy-2-nonenoic lactone mercapturic acid

C14H23NO6S (333.12460180000005)


   
   

8-demethoxyhostasine

8-demethoxyhostasine

C17H19NO6 (333.1212314)


   

cassiarin J|methyl 3-hydroxy-2-methoxy-3-cassiarin A-acetate

cassiarin J|methyl 3-hydroxy-2-methoxy-3-cassiarin A-acetate

C17H19NO6 (333.1212314)


   
   

7-(3-hydroxy-3-methyl-2-oxo-butyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|hydroxyisoorixinone|hydroxylunidonine|Hydroxyluzidonin

7-(3-hydroxy-3-methyl-2-oxo-butyl)-6-methoxy-9-methyl-9H-[1,3]dioxolo[4,5-h]quinolin-8-one|hydroxyisoorixinone|hydroxylunidonine|Hydroxyluzidonin

C17H19NO6 (333.1212314)


   

6alpha-hydroxycrinamidine

6alpha-hydroxycrinamidine

C17H19NO6 (333.1212314)


   
   
   
   
   
   
   
   
   

C16H19N3O5_11-Hydroxy-11-isopropyl-4-methoxy-8-methyl-10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione

NCGC00380446-01_C16H19N3O5_11-Hydroxy-11-isopropyl-4-methoxy-8-methyl-10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione

C16H19N3O5 (333.1324644)


   
   

5,6-dihydro-6-hydroxy-1-[(2E)-1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propen-1-yl]-2(1H)-Pyridinone

5,6-dihydro-6-hydroxy-1-[(2E)-1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propen-1-yl]-2(1H)-Pyridinone

C17H19NO6 (333.1212314)


   

5,6-dihydro-5-hydroxy-1-[(2E)-1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propen-1-yl]-2(1H)-Pyridinone

5,6-dihydro-5-hydroxy-1-[(2E)-1-oxo-3-(3,4,5-trimethoxyphenyl)-2-propen-1-yl]-2(1H)-Pyridinone

C17H19NO6 (333.1212314)


   

Gly Gly Asn Ser

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C11H19N5O7 (333.1284424)


   

Gly Gly Ser Asn

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C11H19N5O7 (333.1284424)


   

Gly Asn Gly Ser

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]acetamido}-3-hydroxypropanoic acid

C11H19N5O7 (333.1284424)


   

Gly Asn Ser Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxypropanamido]acetic acid

C11H19N5O7 (333.1284424)


   

Gly Ser Gly Asn

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]acetamido}-3-carbamoylpropanoic acid

C11H19N5O7 (333.1284424)


   

Gly Ser Asn Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-carbamoylpropanamido]acetic acid

C11H19N5O7 (333.1284424)


   

Asn Gly Gly Ser

(2S)-2-(2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}acetamido)-3-hydroxypropanoic acid

C11H19N5O7 (333.1284424)


   

Asn Gly Ser Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-hydroxypropanamido]acetic acid

C11H19N5O7 (333.1284424)


   

Asn Ser Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]acetamido}acetic acid

C11H19N5O7 (333.1284424)


   
   
   
   
   
   

Ser Gly Gly Asn

(2S)-2-(2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}acetamido)-3-carbamoylpropanoic acid

C11H19N5O7 (333.1284424)


   

Ser Gly Asn Gly

2-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-carbamoylpropanamido]acetic acid

C11H19N5O7 (333.1284424)


   

Ser Asn Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]acetamido}acetic acid

C11H19N5O7 (333.1284424)


   
   
   

[[[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxy]-, (E)-Acetic acid

[[[5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene]amino]oxy]-, (E)-Acetic acid

C15H18F3NO4 (333.11878640000003)


   
   

11-Hydroxy-11-isopropyl-4-methoxy-8-methyl-10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione

11-Hydroxy-11-isopropyl-4-methoxy-8-methyl-10,11-dihydro-6H-oxepino[2,3-d]pyrazino[1,2-a]pyrimidine-6,9(8H)-dione

C16H19N3O5 (333.1324644)


   
   
   

(betaS)-beta-[[(tert-Butoxy)carbonyl]amino]-2,4,5-trifluorobenzenebutanoic acid

(betaS)-beta-[[(tert-Butoxy)carbonyl]amino]-2,4,5-trifluorobenzenebutanoic acid

C15H18F3NO4 (333.11878640000003)


   

Boc-3-(trifluoromethyl)-D-phenylalanine

Boc-3-(trifluoromethyl)-D-phenylalanine

C15H18F3NO4 (333.11878640000003)


   

Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Acid

Boc-(R)-3-Amino-4-(2,4,5-Trifluoro-Phenyl)-Butyric Acid

C15H18F3NO4 (333.11878640000003)


   

3-[(tert-butoxycarbonyl)amino]-3-[3-(trifluoromethyl)phenyl]propanoic acid

3-[(tert-butoxycarbonyl)amino]-3-[3-(trifluoromethyl)phenyl]propanoic acid

C15H18F3NO4 (333.11878640000003)


   

1-(4-Fluorophenyl)-1-(3-dimethylaminopropyl)-5-chlorophthalane

1-(4-Fluorophenyl)-1-(3-dimethylaminopropyl)-5-chlorophthalane

C19H21ClFNO (333.12956180000003)


   
   

(S)-3-((TERT-BUTOXYCARBONYL)AMINO)-3-(2-(TRIFLUOROMETHYL)PHENYL)PROPANOIC ACID

(S)-3-((TERT-BUTOXYCARBONYL)AMINO)-3-(2-(TRIFLUOROMETHYL)PHENYL)PROPANOIC ACID

C15H18F3NO4 (333.11878640000003)


   

(S)-3-((TERT-BUTOXYCARBONYL)AMINO)-3-(3-(TRIFLUOROMETHYL)PHENYL)PROPANOIC ACID

(S)-3-((TERT-BUTOXYCARBONYL)AMINO)-3-(3-(TRIFLUOROMETHYL)PHENYL)PROPANOIC ACID

C15H18F3NO4 (333.11878640000003)


   

(S)-3-((TERT-BUTOXYCARBONYL)AMINO)-3-(4-(TRIFLUOROMETHYL)PHENYL)PROPANOIC ACID

(S)-3-((TERT-BUTOXYCARBONYL)AMINO)-3-(4-(TRIFLUOROMETHYL)PHENYL)PROPANOIC ACID

C15H18F3NO4 (333.11878640000003)


   

(R)-BOC-2-(TRIFLUOROMETHYL)-BETA-PHE-OH

(R)-BOC-2-(TRIFLUOROMETHYL)-BETA-PHE-OH

C15H18F3NO4 (333.11878640000003)


   

BOC-(R)-3-AMINO-3-(3-TRIFLUOROMETHYL-PHENYL)-PROPIONICACID

BOC-(R)-3-AMINO-3-(3-TRIFLUOROMETHYL-PHENYL)-PROPIONICACID

C15H18F3NO4 (333.11878640000003)


   

Boc-(R)-3-Amino-3-(4-trifluoromethylphenyl)-propionic acid

Boc-(R)-3-Amino-3-(4-trifluoromethylphenyl)-propionic acid

C15H18F3NO4 (333.11878640000003)


   

Methyl 1-(2,3-dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylate

Methyl 1-(2,3-dihydroxypropyl)-4-oxo-3-[(phenylmethyl)oxy]-1,4-dihydro-2-pyridinecarboxylate

C17H19NO6 (333.1212314)


   

2-((2-TRIFLUOROMETHYLPHENYLAMINO)METHYLENE)MALONIC ACID DIETHYL ESTER

2-((2-TRIFLUOROMETHYLPHENYLAMINO)METHYLENE)MALONIC ACID DIETHYL ESTER

C15H18F3NO4 (333.11878640000003)


   
   
   

TRP-Glu

TRP-Glu

C16H19N3O5 (333.1324644)


A dipeptide formed from L-tryptophan and L-glutamic acid residues.

   

Methanone, [4-(3-chlorophenyl)-1-piperazinyl](3-ethyl-5-methyl-4-isoxazolyl)

Methanone, [4-(3-chlorophenyl)-1-piperazinyl](3-ethyl-5-methyl-4-isoxazolyl)

C17H20ClN3O2 (333.12439700000004)


   

Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate

Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate

C15H18F3NO4 (333.11878640000003)


   

(2E)-2-(HYDROXYIMINO)-N-(3-METHOXYPHENYL)ACETAMIDE

(2E)-2-(HYDROXYIMINO)-N-(3-METHOXYPHENYL)ACETAMIDE

C21H19NOS (333.11872840000007)


   

2-Methyl-2-propanyl 4-(4-chloro-1H-pyrrolo[2,3-b]pyridin-2-yl)-3, 6-dihydro-1(2H)-pyridinecarboxylate

2-Methyl-2-propanyl 4-(4-chloro-1H-pyrrolo[2,3-b]pyridin-2-yl)-3, 6-dihydro-1(2H)-pyridinecarboxylate

C17H20ClN3O2 (333.12439700000004)


   

ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2-benzothiazole-3-carboxylate

ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2-benzothiazole-3-carboxylate

C16H20BNO4S (333.1206030000001)


   

4-(4-Ethynylphenyl)-2,2:6,2-terpyridine

4-(4-Ethynylphenyl)-2,2:6,2-terpyridine

C23H15N3 (333.126591)


   

4-(4-Methoxybenzylamino)-5-ethoxycarbonyl-2-Methylthiopyrimidine

4-(4-Methoxybenzylamino)-5-ethoxycarbonyl-2-Methylthiopyrimidine

C16H19N3O3S (333.11470640000005)


   

(S)-N-[{3-(4-(3-oxomorpholin-4-yl)phenyl)-2-oxo-1,3-oxazolidin-5-yl}methyl]acetamide

(S)-N-[{3-(4-(3-oxomorpholin-4-yl)phenyl)-2-oxo-1,3-oxazolidin-5-yl}methyl]acetamide

C16H19N3O5 (333.1324644)


   
   

2-(4-Dibenzofuran)carbazole

2-(4-Dibenzofuran)carbazole

C24H15NO (333.115358)


   

DIETHYL 1-BENZYL-3 4-DIHYDROXY-1H-PYRRO&

DIETHYL 1-BENZYL-3 4-DIHYDROXY-1H-PYRRO&

C17H19NO6 (333.1212314)


   

tert-butyl 3-(4-chlorophenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxylate

tert-butyl 3-(4-chlorophenyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridine-5-carboxylate

C17H20ClN3O2 (333.12439700000004)


   

methyl (2r)-2-[(tert-butoxycarbonyl)amino]-3-(2,4,5-trifluorophenyl)propanoate

methyl (2r)-2-[(tert-butoxycarbonyl)amino]-3-(2,4,5-trifluorophenyl)propanoate

C15H18F3NO4 (333.11878640000003)


   
   

Golotimod

Golotimod

C16H19N3O5 (333.1324644)


C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent C274 - Antineoplastic Agent Golotimod (SCV-07), an immunomodulating peptide with antimicrobial activity, significantly increases the efficacy of antituberculosis therapy, stimulates thymic and splenic cell proliferation, and improves macrophage function. Golotimod (SCV-07) inhibits STAT3 signaling and modulates the duration and severity of oral mucositis in animal models that received radiation or a combination of radiation and Cisplatin. Golotimod (SCV-07) is also a potential therapeutic for recurrent genital herpes simplex virus type 2 (HSV-2)[1][2][3].

   

Ethonam nitrate

Ethonam nitrate

C16H19N3O5 (333.1324644)


C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

(11-Amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl)methyl acetate

(11-Amino-7-methoxy-12-methyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl)methyl acetate

C16H19N3O5 (333.1324644)


   
   

1-Tert-butyl-3-[(3-chloro-4-fluorophenyl)methyl]pyrazolo[3,4-d]pyrimidin-4-amine

1-Tert-butyl-3-[(3-chloro-4-fluorophenyl)methyl]pyrazolo[3,4-d]pyrimidin-4-amine

C16H17ClFN5 (333.1156444)


   
   

N,N-diacetyllegionaminate

N,N-diacetyllegionaminate

C13H21N2O8- (333.1297846)


   

5,7-diacetamido-3,5,7,9-tetradeoxy-L-glycero-D-galacto-non-2-ulosonate

5,7-diacetamido-3,5,7,9-tetradeoxy-L-glycero-D-galacto-non-2-ulosonate

C13H21N2O8- (333.1297846)


   

5,7-diacetamido-3,5,7,9-tetradeoxy-D-glycero-D-talo-non-2-ulosonate

5,7-diacetamido-3,5,7,9-tetradeoxy-D-glycero-D-talo-non-2-ulosonate

C13H21N2O8- (333.1297846)


   

5,7-diacetamido-3,5,7,9-tetradeoxy-L-glycero-D-talo-non-2-ulosonate

5,7-diacetamido-3,5,7,9-tetradeoxy-L-glycero-D-talo-non-2-ulosonate

C13H21N2O8- (333.1297846)


   

5,7-bis(acetamido)-3,5,7,9-tetradeoxy-L-glycero-beta-L-manno-2-nonulopyranosonic acid

5,7-bis(acetamido)-3,5,7,9-tetradeoxy-L-glycero-beta-L-manno-2-nonulopyranosonic acid

C13H21N2O8- (333.1297846)


   

N-cyclopentyl-2-[[1-(2-methoxyphenyl)-5-tetrazolyl]thio]acetamide

N-cyclopentyl-2-[[1-(2-methoxyphenyl)-5-tetrazolyl]thio]acetamide

C15H19N5O2S (333.1259394)


   

Glu-Glu-Gly

Glu-Glu-Gly

C12H19N3O8 (333.1172094)


A tripeptide composed of two L-glutamic acid and one glycine residues joined in sequence.

   

Alanyl-glutamyl-aspartic acid

Alanyl-glutamyl-aspartic acid

C12H19N3O8 (333.1172094)


   

2-[[5-(4-Fluorophenyl)-1-methyl-2-imidazolyl]thio]-1-(1-piperidinyl)ethanone

2-[[5-(4-Fluorophenyl)-1-methyl-2-imidazolyl]thio]-1-(1-piperidinyl)ethanone

C17H20FN3OS (333.13110420000004)


   
   
   
   
   
   
   

1-[1-(1-Ethyl-3-methyl-4-pyrazolyl)ethyl]-3-(3-nitrophenyl)thiourea

1-[1-(1-Ethyl-3-methyl-4-pyrazolyl)ethyl]-3-(3-nitrophenyl)thiourea

C15H19N5O2S (333.1259394)


   
   
   
   
   
   

Dibutyl 2-(N-trifluoroacetylamino)ethylphosphonate

Dibutyl 2-(N-trifluoroacetylamino)ethylphosphonate

C12H23F3NO4P (333.1316724)


   

Butyl N-trifluoroacetyl 1-aminoethyl phosphonate

Butyl N-trifluoroacetyl 1-aminoethyl phosphonate

C12H23F3NO4P (333.1316724)


   

2-Trimethylsilyloxy-4-quinolinecarboxylicacid trimethylsilyl ester

2-Trimethylsilyloxy-4-quinolinecarboxylicacid trimethylsilyl ester

C16H23NO3Si2 (333.1216408)


   

5-Tert-butyl-2,3-dimethoxycarbonyl-5,6-dihydropyrrolo(1,2-D)(1,2,4)triazocin-6-one

5-Tert-butyl-2,3-dimethoxycarbonyl-5,6-dihydropyrrolo(1,2-D)(1,2,4)triazocin-6-one

C16H19N3O5 (333.1324644)


   
   

Oglufanide

H-Glu-Trp-OH

C16H19N3O5 (333.1324644)


C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C308 - Immunotherapeutic Agent Oglufanide (H-Glu-Trp-OH) is a dipeptide immunomodulator isolated from calf thymus. Oglufanide inhibits vascular endothelial growth factor (VEGF). Oglufanide can stimulate the immune response to hepatitic C virus (HCV) and intracellular bacterial infections. Oglufanide shows antitumor and anti-angiogenesis activities[1][2][3]. Oglufanide (H-Glu-Trp-OH) is a dipeptide immunomodulator isolated from calf thymus. Oglufanide inhibits vascular endothelial growth factor (VEGF). Oglufanide can stimulate the immune response to hepatitic C virus (HCV) and intracellular bacterial infections. Oglufanide shows antitumor and anti-angiogenesis activities[1][2][3].

   

gamma-Glutamyltryptophan

gamma-Glutamyltryptophan

C16H19N3O5 (333.1324644)


   

Glu-TRP

Glu-TRP

C16H19N3O5 (333.1324644)


A dipeptide composed of L-glutamic acid and L-tryptophan joined by a peptide linkage.

   
   

CP-409092 (hydrochloride)

CP-409092 (hydrochloride)

C17H20ClN3O2 (333.12439700000004)


CP-409092 hydrochloride is a partial agonist of GABAA receptor, with anti-anxiety activity[1].